NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA), a leader in the development of predictive tests and targeted therapeutics from its growing portfolio of proprietary genetic biomarkers, today announced strong revenue growth and continued achievement of its corporate objectives for the fourth quarter and fiscal year ended March 31, 2008.
